NIMVASTID

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, Germany, Ireland, Italy, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug NIMVASTID contains one active pharmaceutical ingredient (API):

1	Rivastigmine UNII PKI06M3IW0 - RIVASTIGMINE
	Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones. Thus, rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficits in dementia associated with Alzheimer’s disease and Parkinson’s disease.
	Read more about Rivastigmine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NIMVASTID Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06DA03	Rivastigmine	N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	09739669, 09739675, 09739681, 09739698, 09739706, 09739712, 09739729, 09739735
EE	Ravimiamet	1420669, 1420670, 1420681, 1420692, 1420704, 1420715, 1420726, 1420737, 1420748, 1420759, 1420760, 1420771, 1420782, 1420793, 1420805, 1420816, 1420827, 1420838, 1420849, 1420850, 1420861, 1420872, 1420883, 1420894, 1420906, 1420917, 1420928, 1420939, 1420940, 1420951, 1420962, 1420973, 1420984, 1420995, 1421008, 1421019, 1421020, 1421031, 1421042, 1421053, 1421064, 1421075, 1421086, 1421097, 1421109, 1470495, 1470507, 1470518, 1470529, 1470675
ES	Centro de información online de medicamentos de la AEMPS	109525004, 109525012, 109525016, 109525018, 109525022, 109525024
FI	Lääkealan turvallisuus- ja kehittämiskeskus	081681, 139959, 159762, 481345
GB	Medicines & Healthcare Products Regulatory Agency	197223, 197231, 197235, 197238
IE	Health Products Regulatory Authority	24472, 24473, 24474, 24475
IT	Agenzia del Farmaco	041673043, 041673106, 041673169, 041673221
LT	Valstybinė vaistų kontrolės tarnyba	1037908, 1037909, 1037910, 1037911, 1037912, 1037913, 1037914, 1037915, 1037916, 1037917, 1037918, 1037919, 1037920, 1037921, 1037922, 1037923, 1037924, 1037925, 1037926, 1037928, 1037929, 1037930, 1037931, 1037932, 1037933, 1037934, 1037935, 1037936, 1037937, 1037938, 1037939, 1037940, 1037941, 1037942, 1037943, 1037944, 1037995, 1037996, 1037997, 1037998, 1037999, 1038000, 1038001, 1038002, 1038003, 1038004, 1054660, 1054661, 1054662, 1056546
PL	Rejestru Produktów Leczniczych	100209493, 100209518, 100209530, 100209547, 100210941, 100210958, 100210964, 100210970
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W54535001, W54535002, W54535003, W54535004, W54535005, W54535006, W54536001, W54536002, W54536003, W54536004, W54536005, W54536006, W54536007, W54537001, W54537002, W54537003, W54537004, W54537005, W54537006, W54538001, W54538002, W54538003, W54538004, W54538005, W54538006, W54539001, W54539002, W54539003, W54539004, W54539005, W54540001, W54540002, W54540003, W54540004, W54540005, W54541001, W54541002, W54541003, W54541004, W54541005, W54542001, W54542002, W54542003, W54542004, W54542005